Latest News for: India wealth fund

Edit

India- Sputnik V: How does Russia's COVID-19 vaccine work?

MENA FN 14 Apr 2021
In India, Russia's sovereign wealth fund, the Russian Direct Investment Fund (RDIF), has partnered with several companies including Dr Reddy's, Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotec, and Stelis Biopharma to manufacture doses; with roughly 900 doses lined up ... 500 per dose in India.
Edit

India approves Russia’s Sputnik V vaccine

La Prensa Latina 13 Apr 2021
The Russian sovereign wealth fund (RDIF) said India was the 60th country to authorize the jab. In a late Monday statement, Kirill Dmitriev, the CEO of the wealth fund, said. “We appreciate the decision of India’s regulatory bodies to grant authorization for Sputnik V.
Edit

UAE's aluminium manufacturer EGA is building up towards an IPO: Mubadala CEO

Gulf News 13 Apr 2021
Abu Dhabi wealth fund Mubadala Investment Co ... The wealth fund has teams studying the opportunity and looking at possible returns on investing in Saudi Arabia, according to Al Mubarak ... Earlier this month, Bloomberg reported that the wealth fund had started preparations for a US IPO that could value the business at about $20 billion.
Edit

India to produce 850 Million Sputnik V doses annually: RDIF

India TV 13 Apr 2021
"The vaccine has been approved for use in countries with a total population of 3 billion people or about 40 per cent of the global population, and India has become the 60th country to approve Sputnik V, RDIF", Russia's sovereign wealth fund, said in a statement.
Edit

India authorizes emergency use of Russian COVID-19 vaccine

China.dot.org 13 Apr 2021
Reddy's Laboratories, which will be manufacturing the vaccines in India ... "The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country.
Edit

More Sputnik V partnerships in India in 2 weeks: RDIF CEO

Business Line 13 Apr 2021
Russia and India will be the largest production hubs for Sputnik V, the Covid-19 vaccine developed by Russia’s Gamalaya Centre, said Kirill Dmitriev, Chief Executive Officer of the Russian Direct Investment Fund (RDIF).
Edit

India approves Russia's Sputnik V vaccine for emergency use

Kyodo 13 Apr 2021
The ministry said the Drugs Controller General of India, which falls under the ministry's purview, is granting "permission for restricted use in emergency situations." ... The Russian sovereign wealth fund said it has reached agreements with leading pharmaceutical companies in India, aimed at production of more than 850 million doses per year.
Edit

India becomes 60th country to approve Russia's Sputnik V vaccine

The Telegraph India 13 Apr 2021
The vaccine has been approved for use in countries with a total population of 3 billion people or about 40 per cent of the global population, and India has become the 60th country to approve Sputnik V, RDIF, Russia's sovereign wealth fund, said in a statement.
Edit

India Poised To Approve Russia's Sputnik V COVID-19 Vaccine

Radio Free Europe 13 Apr 2021
"India is the most populated country to register the Russian vaccine ... Reddy's, which is marketing the vaccine in India, is RDIF’s local partner. The Russian sovereign wealth fund said it had agreements with five Indian pharmaceutical companies to produce more than 850 million doses a year for the population in India and global distribution.
Edit

India to produce 850 mn Sputnik doses annually: RDIF

Business Line 13 Apr 2021
The vaccine has been approved for use in countries with a total population of three billion people or about 40 per cent of the global population, and India has become the 60th country to approve Sputnik V, RDIF, Russia’s sovereign wealth fund, said in a statement.
Edit

India becomes 60th country to authorise Sputnik V vaccine

Ghana Web 13 Apr 2021
India has become the 60th country to authorize the use of the ... "The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country.
Edit

India to make 85 crore Sputnik doses annually, can vaccinate 42 crore people

Live Mint 13 Apr 2021
The vaccine has been approved for use in countries with a total population of 3 billion people or about 40 per cent of the global population, and India has become the 60th country to approve Sputnik V, RDIF, Russia's sovereign wealth fund, said in a statement.
Edit

India approves Sputnik V for emergency use; to produce 850 mn doses annually

The Siasat Daily 13 Apr 2021
The vaccine has been approved for use in countries with a total population of 3 billion people or about 40 per cent of the global population, and India has become the 60th country to approve Sputnik V, RDIF, Russia’s sovereign wealth fund, said in a statement.
Edit

India records 161,736 more coronavirus infections

Anadolu Agency 13 Apr 2021
India registered nearly 162,000 new coronavirus cases during the past 24 hours on Tuesday, a Health Ministry statement said ... Amid the massive surge, India has now approved the use of the Russian Sputnik V COVID-19 vaccine, the Russian Direct Investment Fund, which is Russia's sovereign wealth fund, confirmed in a statement late Monday night.
Edit

Dr Reddy's gets EUA for Sputnik V

The Times of India 13 Apr 2021
Commenting on the development, Dr Reddy’s Laboratories co-chairman and managing director said, “We are very pleased to obtain the emergency use authorisation for Sputnik V in India ... In September 2020, Dr Reddy’s had partnered with the Russian sovereign wealth fund, (), to conduct the clinical trials of Sputnik V and distribute the vaccine in India.
×